A retrospective study investigating efficacy of switching therapy from bevacizumab or ranibizumab to aflibercept in patients with recurrent and refractory neovascular age-related macular degeneration.
Phase of Trial: Phase IV
Latest Information Update: 10 Feb 2016
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 10 Feb 2016 New trial record